The Evanosky Foundation supports pediatric leukodystrophy research, universal newborn screening, and children and families affected by a leukodystrophy, lysosomal storage disorders, or other disabling pediatric conditions. MLD is a rare, genetic, degenerative, neurometabolic disorder that affects approximately one in 40,000 people (primarily children) worldwide. It is an inherited disease, but parents are typically not affected. At present, it is a disease for which there is no cure, but we are actively fighting it on a number of fronts: